Sectoral Asset Management Inc Atea Pharmaceuticals, Inc. Transaction History

Sectoral Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$3.0 - $3.79 $296,772 - $374,921	98,924 Added 19.72%	600,461 $1.8 Million
Q2 2023 Aug 11, 2023	BUY	$3.21 - $5.06 $387,405 - $610,676	120,687 Added 31.69%	501,537 $1.88 Million
Q1 2023 May 12, 2023	BUY	$3.0 - $4.97 $298,341 - $494,251	99,447 Added 35.34%	380,850 $1.28 Million
Q4 2022 Feb 10, 2023	BUY	$4.35 - $6.17 $1.22 Million - $1.74 Million	281,403 New	281,403 $1.35 Million
Q3 2021 Nov 15, 2021	SELL	$21.33 - $35.06 $11.5 Million - $18.9 Million	-538,884 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$19.22 - $59.08 $15.4 Million - $47.3 Million	-800,000 Reduced 59.75%	538,884 $11.6 Million
Q1 2021 May 14, 2021	SELL	$41.42 - $88.44 $6.35 Million - $13.5 Million	-153,206 Reduced 10.27%	1,338,884 $82.7 Million
Q4 2020 Feb 12, 2021	BUY	$26.36 - $41.78 $39.3 Million - $62.3 Million	1,492,090 New	1,492,090 $62.3 Million

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $272M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.